Trial Outcomes & Findings for The Effect of Local Anesthesia on Control of Intraoperative Physiologic Parameters and Post Operative Comfort (NCT NCT04500158)
NCT ID: NCT04500158
Last Updated: 2024-09-19
Results Overview
The Parent's Postoperative Pain Measure ( abbreviated: PPPM) Scale consists of 15 questions with scores ranging from 0 to 15, with one point assigned to each question answered with a "Yes" and therefore higher scores indicating worse postoperative pain. A score of 6 or greater is considered clinically significant pain which was tallied for the primary outcome measure (i..e number of participants experiencing clinically significant postoperative pain).
COMPLETED
PHASE3
59 participants
in the evening of the day of surgery, up to 10 hours
2024-09-19
Participant Flow
Participant milestones
| Measure |
Local Anesthesia
Participants will receive local anesthesia in addition to the standard care general anesthesia
Lidocaine: 2% Lidocaine with 1:100,000 epi
|
Standard Care
Participants will receive standard care general anesthesia
|
|---|---|---|
|
Overall Study
STARTED
|
32
|
27
|
|
Overall Study
COMPLETED
|
15
|
16
|
|
Overall Study
NOT COMPLETED
|
17
|
11
|
Reasons for withdrawal
| Measure |
Local Anesthesia
Participants will receive local anesthesia in addition to the standard care general anesthesia
Lidocaine: 2% Lidocaine with 1:100,000 epi
|
Standard Care
Participants will receive standard care general anesthesia
|
|---|---|---|
|
Overall Study
Physician Decision
|
17
|
11
|
Baseline Characteristics
The Effect of Local Anesthesia on Control of Intraoperative Physiologic Parameters and Post Operative Comfort
Baseline characteristics by cohort
| Measure |
Local Anesthesia
n=15 Participants
Participants will receive local anesthesia in addition to the standard care general anesthesia
Lidocaine: 2% Lidocaine with 1:100,000 epi
|
Standard Care
n=16 Participants
Participants will receive standard care general anesthesia
|
Total
n=31 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
15 Participants
n=5 Participants
|
16 Participants
n=7 Participants
|
31 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
6 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
12 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
9 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
19 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
5 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
6 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
10 Participants
n=5 Participants
|
15 Participants
n=7 Participants
|
25 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
5 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
16 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
3 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
7 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
10 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: in the evening of the day of surgery, up to 10 hoursPopulation: Number of parents that completed the parents post operative pain measure
The Parent's Postoperative Pain Measure ( abbreviated: PPPM) Scale consists of 15 questions with scores ranging from 0 to 15, with one point assigned to each question answered with a "Yes" and therefore higher scores indicating worse postoperative pain. A score of 6 or greater is considered clinically significant pain which was tallied for the primary outcome measure (i..e number of participants experiencing clinically significant postoperative pain).
Outcome measures
| Measure |
Local Anesthesia
n=15 Participants
Participants will receive local anesthesia in addition to the standard care general anesthesia
Lidocaine: 2% Lidocaine with 1:100,000 epi
|
Standard Care
n=16 Participants
Participants will receive standard care general anesthesia
|
|---|---|---|
|
Post Operative Pain
|
13 Participants
|
10 Participants
|
SECONDARY outcome
Timeframe: start of procedure to end of procedure, the intraoperative time frmePopulation: Number of subjects that completed the study.
Will report the mean and standard deviation of number of teeth treated
Outcome measures
| Measure |
Local Anesthesia
n=15 Participants
Participants will receive local anesthesia in addition to the standard care general anesthesia
Lidocaine: 2% Lidocaine with 1:100,000 epi
|
Standard Care
n=16 Participants
Participants will receive standard care general anesthesia
|
|---|---|---|
|
Number of Teeth Treated
|
8.6 teeth treated
Standard Deviation 3.4
|
7.4 teeth treated
Standard Deviation 3.4
|
SECONDARY outcome
Timeframe: start of procedure to end of procedure, minutesPopulation: Number of subjects that completed the study.
Will report the mean and standard deviation of the procedure time
Outcome measures
| Measure |
Local Anesthesia
n=15 Participants
Participants will receive local anesthesia in addition to the standard care general anesthesia
Lidocaine: 2% Lidocaine with 1:100,000 epi
|
Standard Care
n=16 Participants
Participants will receive standard care general anesthesia
|
|---|---|---|
|
Procedure Time
|
85.4 procedure time in minutes
Standard Deviation 32.8
|
70.6 procedure time in minutes
Standard Deviation 29
|
SECONDARY outcome
Timeframe: time from after procedure to through time in the post-anesthesia care unit in minutesPopulation: Number of subjects that completed the study
Will report the mean and standard deviation of time after the procedure to through time in the post-anesthesia care unit
Outcome measures
| Measure |
Local Anesthesia
n=15 Participants
Participants will receive local anesthesia in addition to the standard care general anesthesia
Lidocaine: 2% Lidocaine with 1:100,000 epi
|
Standard Care
n=16 Participants
Participants will receive standard care general anesthesia
|
|---|---|---|
|
PACU Time
|
39.8 Time in minutes
Standard Deviation 11.6
|
39.9 Time in minutes
Standard Deviation 9.3
|
Adverse Events
Local Anesthesia
Standard Care
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Caroline Carrico
Virginia Commonwealth University
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place